Literature DB >> 15355435

The dynamics of X-inactivation skewing as women age.

C Hatakeyama1, C L Anderson, C L Beever, M S Peñaherrera, C J Brown, W P Robinson.   

Abstract

Non-random X-chromosome inactivation (XCI) has been associated with X-linked diseases, neoplastic diseases, recurrent pregnancy loss, and trisomy risk. It also occurs more commonly in older female populations. To understand the etiology of non-random XCI and utilize this assay appropriately in clinical research and practice, the age-related alteration in XCI patterns in normal females needs to be clearly defined. In the present study, we evaluated the XCI status in 350 unselected women aged 0-88 years with unknown history of genetic disorders or abnormal pregnancies. DNA samples were extracted from peripheral blood and analyzed by a methylation-based assay at the androgen receptor locus. A weak but significant positive correlation was observed between age and degree of skewing in XCI over the whole age range (r = 0.23, p < 0.0001), and skewing values become non-normally distributed at older ages. However, the increase in skewed XCI appears to be more pronounced after age 30 than at younger ages. This trend supports the model of increased skewing with age as a consequence of hematopoietic stem cell senescence. An alternative possibility is that there is allele-specific loss of methylation with time that results in the appearance of increased XCI skewing using a methylation-based assay.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15355435     DOI: 10.1111/j.1399-0004.2004.00310.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  49 in total

1.  Trisomic pregnancy and intermediate CGG repeat length at the FMR1 locus.

Authors:  J Kline; A Kinney; S Brown; B Levin; K Oppenheimer; D Warburton
Journal:  Hum Reprod       Date:  2012-04-06       Impact factor: 6.918

Review 2.  Adult-onset presentations of genetic immunodeficiencies: genes can throw slow curves.

Authors:  Katharine S Nelson; David B Lewis
Journal:  Curr Opin Infect Dis       Date:  2010-08       Impact factor: 4.915

3.  A longitudinal study of epigenetic variation in twins.

Authors:  Chloe Chung Yi Wong; Avshalom Caspi; Benjamin Williams; Ian W Craig; Renate Houts; Antony Ambler; Terrie E Moffitt; Jonathan Mill
Journal:  Epigenetics       Date:  2010-08-16       Impact factor: 4.528

4.  The Role of X-Chromosome Inactivation in Retinal Development and Disease.

Authors:  Abigail T Fahim; Stephen P Daiger
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

5.  X chromosome-inactivation patterns of 1,005 phenotypically unaffected females.

Authors:  James M Amos-Landgraf; Amy Cottle; Robert M Plenge; Mike Friez; Charles E Schwartz; John Longshore; Huntington F Willard
Journal:  Am J Hum Genet       Date:  2006-07-27       Impact factor: 11.025

6.  No evidence that skewing of X chromosome inactivation patterns is transmitted to offspring in humans.

Authors:  Véronique Bolduc; Pierre Chagnon; Sylvie Provost; Marie-Pierre Dubé; Claude Belisle; Marianne Gingras; Luigina Mollica; Lambert Busque
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

Review 7.  X chromosome inactivation in clinical practice.

Authors:  Karen Helene Orstavik
Journal:  Hum Genet       Date:  2009-04-25       Impact factor: 4.132

8.  Hematopoiesis is not clonal in healthy elderly women.

Authors:  Sabina I Swierczek; Neeraj Agarwal; Roberto H Nussenzveig; Gerald Rothstein; Andrew Wilson; Andrew Artz; Josef T Prchal
Journal:  Blood       Date:  2008-07-18       Impact factor: 22.113

Review 9.  Sexual dimorphism in autoimmunity.

Authors:  Kira Rubtsova; Philippa Marrack; Anatoly V Rubtsov
Journal:  J Clin Invest       Date:  2015-04-27       Impact factor: 14.808

10.  FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure.

Authors:  Karla L Bretherick; Margo R Fluker; Wendy P Robinson
Journal:  Hum Genet       Date:  2005-06-02       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.